Tech Company Financing Transactions
TandemAI Funding Round
Qiming Ventures, Eight Roads and F-Prime Capital participated in a $35 million Series A funding round for TandemAI. The financing closed on 3/1/2023.
Transaction Overview
Company Name
Announced On
3/1/2023
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to to increase its wet lab capacity to over 500 chemists and biologists and continue the development of its computational tools to service the expanding biotech client base in the U.S. and China.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Building 10 No. 860 Xinyang Rd. Lingang New Area Pilot Free
Shanghai, 201208
China
Shanghai, 201208
China
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff He
Browse more venture capital transactions:
Prev: 3/1/2023: Circ venture capital transaction
Next: 3/1/2023: Chroma Medicine venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs